Old Web
English
Sign In
Acemap
>
authorDetail
>
Anne Hawdon
Anne Hawdon
Eli Lilly and Company
Diabetes mellitus
Antibody
Psychiatry
Disease
Psychology
3
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Donanemab (LY3002813) dose-escalation study in Alzheimer's disease.
2021
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Stephen L. Lowe
Brian A. Willis
Anne Hawdon
Fanni Natanegara
Laiyi Chua
Joanne Foster
Sergey Shcherbinin
Paul A. Ardayfio
John R. Sims
Show All
Source
Cite
Save
Citations (9)
SIGNIFICANT AND SUSTAINED FLORBETAPIR F18 UPTAKE REDUCTION IN PATIENTS WITH SYMPTOMATIC ALZHEIMER’S DISEASE WITH LY3002813, A β-AMYLOID PLAQUE-SPECIFIC ANTIBODY
2018
Alzheimers & Dementia
Adam S. Fleisher
Stephen L. Lowe
Peng Liu
Sergey Shcherbinin
Li Li
Laiyi Chua
Masako Nakano
Anne Hawdon
Brian A. Willis
Adam J. Schwarz
Ronald B. DeMattos
Mark A. Mintun
Michael C. Irizarry
Show All
Source
Cite
Save
Citations (4)
SAFETY, PHARMACOKINETICS (PK), AND FLORBETAPIR F-18 POSITRON EMISSION TOMOGRAPHY (PET) AFTER MULTIPLE DOSE ADMINISTRATION OF LY3002813, A β-AMYLOID PLAQUE-SPECIFIC ANTIBODY, IN ALZHEIMER’S DISEASE (AD)
2016
Alzheimers & Dementia
Michael C. Irizarry
John R. Sims
Stephen L. Lowe
Masako Nakano
Anne Hawdon
Brian A. Willis
Celedon Gonzales
Peng Liu
Shino Fujimoto
Robert A. Dean
Robert J. Konrad
Sergey Shcherbinin
Adam J. Schwarz
Mark A. Mintun
Michael D. Devous
Ronald B. DeMattos
Show All
Source
Cite
Save
Citations (9)
1